Diversity advocate to address med school grads
Augustus White, a professor at Harvard Medical School, was the first African-American to graduate from Stanford’s medical school in 1961.
Senior vice chairs appointed
Andrew Hoffman and Ann Weinacker will strengthen ties between the Department of Medicine and other units within Stanford Medicine.
Rubin, Hernandez-Boussard receive funds
A collaboration between Stanford Department of Medicine and AstraZeneca is distributing its second round of grants to two innovative research projects.
Trial led by Mark Genovese wins award
In the trial, a new drug proved safe and effective for hard-to-treat rheumatoid arthritis patients. A national organization of senior researchers named the trial one of the top 10 for 2016.
Schneider to chair microbiology and immunology
David Schneider, whose research focuses on resilience to infection and developing mathematical models to predict recovery and well-being, succeeds Peter Sarnow in post.
Stanford experts to discuss hot topics in medicine
A free webinar on the Zika virus will be the first in a series of continuing medical education seminars on controversial issues in medicine, hosted by Stanford experts.
Ronald Levy and Howard Chang honored
Stanford cancer researchers Ronald Levy and Howard Chang have been named Outstanding Investigators by the National Cancer Institute. They were awarded grants of up to $7 million over six years to advance their studies.
Drug discovery conference set for April 24
The daylong conference at Stanford will create a platform for discussion of policy, research and venture topics with a variety of speakers.
Grants awarded for cancer immunotherapy
The Parker Institute for Cancer Immunotherapy at Stanford hands out its first grants to researchers who hope to translate scientific discoveries into new therapies for cancer patients.
Team places third in data analysis contest
The Stanford-led team used the data to develop and validate a clinical decision score that identifies patients likely to experience benefits when undergoing intensive blood pressure treatment.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.